Placing the Next Bet: The Global Race in Oncology

Session details:

The global oncology landscape is being fundamentally reshaped. Scientific breakthroughs, clinical development capabilities, and investment are expanding beyond traditional markets, redefining where innovation happens, where capital flows, and how the next generation of cancer therapies reaches patients.

 As global competition intensifies, the ability to build strategic partnerships, access differentiated science, deploy capital effectively, and leverage world-class clinical infrastructure will increasingly determine who leads the next wave of oncology innovation.

 Leaders from cancer research, biopharma, and government will explore how the global innovation ecosystem is evolving, where new opportunities are emerging, and how the U.S. can strengthen its leadership by embracing international collaboration, strategic investment, and a more globally connected approach to accelerating breakthroughs for patients.